| Literature DB >> 26630380 |
Matthew J Durand1,2, Spencer A Murphy3, Kathleen K Schaefer4, Sandra K Hunter4, Brian D Schmit3, David D Gutterman2, Allison S Hyngstrom4.
Abstract
Individuals with chronic stroke have reduced perfusion of the paretic lower limb at rest; however, the hyperemic response to graded muscle contractions in this patient population has not been examined. This study quantified blood flow to the paretic and non-paretic lower limbs of subjects with chronic stroke after submaximal contractions of the knee extensor muscles and correlated those measures with limb function and activity. Ten subjects with chronic stroke and ten controls had blood flow through the superficial femoral artery quantified with ultrasonography before and immediately after 10 second contractions of the knee extensor muscles at 20, 40, 60, and 80% of the maximal voluntary contraction (MVC) of the test limb. Blood flow to the paretic and non-paretic limb of stroke subjects was significantly reduced at all load levels compared to control subjects even after normalization to lean muscle mass. Of variables measured, increased blood flow after an 80% MVC was the single best predictor of paretic limb strength, the symmetry of strength between the paretic and non-paretic limbs, coordination of the paretic limb, and physical activity. The impaired hemodynamic response to high intensity contractions was a better predictor of lower limb function than resting perfusion measures. Stroke-dependent weakness and atrophy of the paretic limb do not explain the reduced hyperemic response to muscle contraction alone as the response is similarly reduced in the non-paretic limb when compared to controls. These data may suggest a role for perfusion therapies to optimize rehabilitation post stroke.Entities:
Mesh:
Year: 2015 PMID: 26630380 PMCID: PMC4667998 DOI: 10.1371/journal.pone.0144023
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of all Subjects.
| Characteristic | Control (n = 9) | Stroke (n = 10) |
|---|---|---|
| Sex, Male | 6 | 6 |
| Age (yr) | 60±6 | 63±7 |
| Height (cm) | 173.2±14.7 | 172.1±11.7 |
| Weight (kg) | 80.3±14.6 | 85.9±19.7 |
| Body Mass Index (kg/m2) | 27±4 | 29±4 |
| Total Body Fat (%) | 35.8±6.5 | 39.8±4.5 |
| Estimated Visceral Fat (%) | 27.3±10.5 | 34.0±11.7 |
| Waist Circumference (cm) | 94.4±7.7 | 103.8±11.4 |
| Hip Circumference (cm) | 103.4±6.5 | 107.8±4.0 |
| Waist to Hip Ratio | 0.91±0.04 | 1.00±0.08 |
| Total Cholesterol (mg/dl) | 200±22 | 170±32 |
| LDL Cholesterol (mg/dl) | 123±26 | 91±26 |
| HDL Cholesterol (mg/dl) | 60±21 | 59±21 |
| Triglycerides (mg/dl) | 94±50 | 104±48 |
| Systolic Blood Pressure (mmHg) | 125±9 | 123±15 |
| Diastolic Blood Pressure (mmHg) | 80±11 | 74±9 |
| Heart Rate (bpm) | 73±18 | 75±8 |
| Fugl-Meyer Score | NA | 23±7 |
| Physical Activity (Met-h/week) | 14±7 | 13 ±7 |
All values are expressed as mean ± SD. HDL, high density lipoprotein; LDL, low density lipoprotein; n, number of subjects.
*Significant difference (p<0.05) Stroke vs. Control–unpaired t-test.
Leg strength, size and composition of all subjects.
| Characteristic | Control (n = 9) | Non Paretic (n = 10) | Paretic (n = 10) |
|---|---|---|---|
| Maximum Voluntary Contraction (Nm) | 134.4±48.1 | 87.2±53.0 | 50.6±31.3 |
| Thigh Circumference (cm) | 54.7±4.6 | 53.1±3.9 | 51.2±4.7 |
| Calf Circumference (cm) | 37.5±3.2 | 36.7±3.5 | 34.5±2.5 |
| Total Lower Limb Mass (kg) | 13.0±2.6 | 14.3±2.9 | 13.0±0.8 |
| Lean Muscle Mass of Lower Limb (kg) | 8.4±2.7 | 9.0±2.7 | 7.8±2.3 |
| Fat Mass of Lower Limb (kg) | 4.1±1.3 | 4.7±0.6 | 4.7±0.6 |
| Fat Tissue in Lower Limb (%) | 32.5±9.9 | 35.8±8 | 38.4±7.3 |
| Femoral Artery Diameter (mm) | 6.46±1.11 | 6.03±1.23 | 5.08±1.04 |
All values are expressed as mean ± SD. n, number of subjects.
*Significant difference (p<0.05) Control vs. Paretic–one way ANOVA.
#Significant difference (p<0.05) Paretic vs. Non Paretic–paired t-test
Vascular measurements during submaximal isometric contraction protocol.
| Condition | Test Limb | Percent Maximum Voluntary Contraction | ||||
|---|---|---|---|---|---|---|
| Rest | 20 | 40 | 60 | 80 | ||
| Heart Rate (bpm) | Control | 73±14 | 76±13 | 79±14 | 80±15 | 81±18 |
| Non Paretic—Equal Effort | 73±8 | 73±11 | 77±8 | 75±9 | 80±11 | |
| Non Paretic—Equal Torque | NA | 75±12 | 74±7.5 | 76±8 | 77±10 | |
| Paretic | 73±8 | 73±10 | 74±8 | 78±10 | 77±10 | |
| Femoral Artery Diameter (mm) | Control | 6.46±1.11 | 6.49±1.09 | 6.47±1.11 | 6.47±1.09 | 6.48±1.11 |
| Non Paretic—Equal Effort | 6.03±1.23 | 6.07±1.25 | 6.00±1.24 | 6.04±1.27 | 6.06±1.22 | |
| Non Paretic—Equal Torque | NA | 6.10±1.15 | 6.08±1.24 | 6.11±1.23 | 6.10±1.18 | |
| Paretic | 5.08±1.08 | 5.09±1.12 | 5.10±1.21 | 5.05±1.11 | 5.04±1.12 | |
| Mean Blood Flow Velocity (cm/s) | Control | 6.9±2.0 | 11.3±4.2 | 13.1±5.0 | 15.2±6.6 | 19.0±4.4 |
| Non Paretic—Equal Effort | 6.2±2.5 | 8.1±3.1 | 11.0±4.7 | 12.7±1.9 | 13.7±5.0 | |
| Non Paretic—Equal Torque | NA | 7.2±3.2 | 9.6±4.0 | 12.2±7.3 | 11.8±3.7 | |
| Paretic | 6.1±1.7 | 7.2±1.8 | 9.9±3.5 | 10.6±3.6 | 11.0±3.8 | |
| Peak Blood Flow Velocity (cm/s) | Control | 62.5±11.8 | 69.6±13.8 | 74.1±17.1 | 83.2±11.7 | 87.2±17.9 |
| Non Paretic—Equal Effort | 65.2±21.7 | 67.3±20.6 | 68.9±20.4 | 72.4±22.8 | 77.9±5.9 | |
| Non Paretic—Equal Torque | NA | 67.3±3.6 | 69.0±7.0 | 75.5±8.6 | 72.7±14.5 | |
| Paretic | 62.2±17.0 | 64.9±11.1 | 73.0±13.9 | 70.9±11.5 | 74.4±15.2 | |
| Blood Flow (mL/min) | Control | 136±56 | 260±99 | 343±137 | 388±89 | 443±172 |
| Non Paretic—Equal Effort | 110±69 | 161±92 | 207±110 | 237±118 | 264±135 | |
| Non Paretic—Equal Torque | NA | 129±51 | 171±73 | 205±112 | 217±114 | |
| Paretic | 80±40 | 101±49 | 141±76 | 137±70 | 163±85 | |
| Peak Shear Stress (dyne/cm2) | Control | 27.7±7.3 | 30.7±8.7 | 33.0±10.5 | 37.3±9.8 | 38.4±9.1 |
| Non Paretic—Equal Effort | 31.1±14.3 | 32.4±15.1 | 32.7±12.8 | 33.9±16.7 | 37.1±13.1 | |
| Non Paretic—Equal Torque | 34.4±15.1 | 34.6±15.2 | 36.3±17.5 | 39.8±23.2 | 36.5±14.4 | |
| Paretic | 36.0±14.5 | 38.0±15.3 | 42.6±16.9 | 41.3±14.4 | 43.3±15.5 | |
All values are expressed as mean ± SD. NA, Not applicable. The same resting values were used in the equal torque and equal effort conditions for the non-paretic lower limb. Control n = 9; Non Paretic–Equal Effort n = 10; Non Paretic–Equal Torque n = 9; Paretic n = 10. n = number of subjects.
*Significant difference (p<0.05) vs. Control–one way ANOVA.
Fig 1Representative ultrasound images showing blood flow through either the superficial femoral artery of a neurologically intact control subject or the paretic and non-paretic lower limb of a stroke subject at rest or immediately following an 80% MVC.
Paretic and non-paretic superficial femoral artery images are from the same subject. D, diameter; FBF, femoral blood flow.
Fig 2(A) Blood flow through the superficial femoral artery was significantly reduced in the paretic (n = 10) and non-paretic lower limb (n = 10) of stroke subjects in response to 10-second submaximal isometric contractions of the knee extensor muscles compared to age and sex matched control subjects (n = 9). All subjects performed work based on the perceived maximal effort of the test limb (i.e., equal effort). *Significant difference (p<0.05) control vs. paretic and non-paretic lower limb, mixed model repeated measures ANOVA. (B) Blood flow through the superficial femoral artery was similar between the paretic (n = 10) and non-paretic (n = 9) lower limb of stroke subjects when the non-paretic limb achieved target torques equal to the paretic limb (i.e., equal torque). Blood flow data could not be quantified in the non-paretic limb of one subject following the equal torque test session. n, number of subjects.
Fig 3An increased blood flow response in the paretic lower limb following an 80% MVC was positively correlated with (A) paretic limb strength, (B) symmetry of limb strength, (C) Fugl Meyer score and (D) physical activity.
There were no correlations between any of the measured parameters and paretic lower limb blood flow at rest.